Genetic risk for mental health disorders is associated with brain structure and the occurrence of psychosis-like experiences in children between 9 and 10 years of age.
Subtle differences in perception during teenage years predict the development of hallucinations, delusions, and psychosis later in life.
A new theory proposes an imbalance of blood proteins involved in the immune system and in blood clotting networks leads to inflammation that contributes to the development of psychosis.
Prescribing SSRIs during late childhood to those with genetic risk factors for psychosis can reduce the deterioration of intellectual abilities, a new study reveals. SSRIs appear to have a neuroprotective effect for certain brain areas associated with the onset of psychosis if provided early.
Adolescents with higher levels of Omega 3 fatty acids in their blood had a decreased risk of developing psychosis as they entered into early adulthood. At the age of 24, those with psychosis had lower levels of DHA than those without the disorder.
Brain scans revealed, compared to women with low risk for postpartum psychosis, new mothers in high-risk groups had altered brain connectivity in networks associated with goal-orientated behaviors.
A link has been identified between psychosis and a genetic change that alters the immune system in the brain. Researchers found people with psychosis associated with bipolar disorder had decreased expression of GRK3. This led to an increased amount of kynurenic acid in the brain.